News Press Releases

45 Stocks Moving In Tuesday's Mid-Day Session

CLRB, CPRX, CVLG, DBI, STLA | March 19, 2019

Gainers

Vaxart, Inc. (NASDAQ: VXRT) shares jumped 145.2 percent to $4.12 after the company initiated a Phase 1b clinical trial for its bivalent norovirus vaccine.
Sorrento Therapeutics, Inc. (NASDAQ: SRNE) shares rose 23.3 percent to $3.39.
Altimmune, Inc. (NASDAQ: ALT) climbed 22.8 percent to $3.5477 after reporting 'positive' results from NasoVAX extension study'.
StoneCo Ltd. (NASDAQ: STNE) shares gained 21.4 percent to $42.00 after the company reported higher-than-expected Q4 EPS and sales results.
Blucora Inc (NASDAQ: BCOR) jumped 20.5 percent to $34.19 after the company reported a $100 million buyback, raised its FY19 EPS and sales guidance, and announced it will acquire 1st Global for $180 million.
IMAC Holdings, Inc. (NASDAQ: IMAC) shares rose 20.1 percent to $3.65.
Forterra, Inc. (NASDAQ: FRTA) gained 17.7 percent to $4.7896.
Professional Diversity Network, Inc. (NASDAQ: IPDN) surged 16.1 percent to $3.25.
Evolus, Inc. (NASDAQ: EOLS) gained 15.5 percent to $27.54, despite reporting mixed Q4 EPS, after the company secured a $100 million debt facility with Oxford Finance LLC.
ENDRA Life Sciences Inc. (NASDAQ: NDRA) shares rose 13.8 percent to $2.7423.
Aytu Bioscience Inc (NASDAQ: AYTU) climbed 13.4 percent to $1.95 after the company announced two recent publications highlighting summarized findings from its MY-T study.
Cellectar Biosciences Inc (NASDAQ: CLRB) gained 13.1 percent to $3.10 after the FDA granted an exemption to the import alert for Cellectar's CLR 131 in pediatric and adolescent patients.
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) gained 11.5 percent to $7.66 after Oppenheimer initiated an Outperform rating on the stock and announced a $28 price target.
Michaels Companies Inc (NASDAQ: MIK) rose 11.4 percent to $13.14 after reporting better-than-expected results for its fourth quarter.
Ferro Corporation (NYSE: FOE) gained 11 percent to $20.96 after S&P Dow Jones Indices announced that Ferro will replace First Financial Bankshares in the S&P SmallCap 600 on Friday, March 22.
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) surged 11 percent to $3.42. Catalyst Pharmaceuticals reported a loss of 14 cents per share compared to the loss of 6 cents per share a year ago and the 12 cents per share consensus estimate. The company reported revenues of $500,000 for the recent fourth quarter.
SemiLEDs Corporation (NASDAQ: LEDS) surged 9.2 percent to $3.8664.
Tronox Ltd (NYSE: TROX) gained 8.1 percent to $13.04 following a media report the company will be selling its North American titanium dioxide business for $700 million.
Sibanye Gold Limited (NYSE: SBGL) rose 7.8 percent to $4.42.
Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) fell 7.4 percent to $2.30 after climbing 14.9439 percent on Monday.
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) shares gained 7.2 percent to $28.23.
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) surged 7.2 percent to $5.19.
X Financial (NYSE: XYF) shares rose 6 percent to $6.44 following Q4 results.
Syneos Health, Inc. (NASDAQ: SYNH) rose 5.8 percent to $50.18 after the company reported higher-than-expected Q4 EPS results. The company also issued FY19 EPS guidance on the high-end of analyst estimates.
Advanced Micro Devices, Inc. (NASDAQ: AMD) gained 5.8 percent to $24.60. Shares of several semiconductor companies are trading higher after NVIDIA teamed up with Amazon Web Services IoT to bring AI to millions of connected devices.
Fiat Chrysler Automobiles N.V. (NYSE: FCAU) shares rose 4 percent to $15.10 after the Peugeot family hinted it could be interested in acquiring Fiat as a part of PSA Group.
NVIDIA Corporation (NASDAQ: NVDA) rose 3.6 percent to $174.91 after the company teamed up with Amazon Web Services IoT to bring AI to millions of connected devices.

Check out these big penny stock gainers and losers

Losers

resTORbio, Inc. (NASDAQ: TORC) dipped 20.4 percent to $7.20 after the company reported Q4 results and announced a $50 million common stock offering.
Urovant Sciences Ltd (NASDAQ: UROV) shares fell 20.2 percent to $11.10 after the company announced its Vibegron met its primary endpoints in a phase 3 trial.
AquaBounty Technologies, Inc. (NASDAQ: AQB) dropped 19.4 percent to $2.2568. AquaBounty priced its 3.35 million share common stock offering at $2.25 per share.
Selecta Biosciences, Inc. (NASDAQ: SELB) shares declined 17.7 percent to $2.52
DSW Inc. (NYSE: DSW) shares fell 15.7 percent to $21.38 after reporting downbeat quarterly earnings.
Orion Group Holdings, Inc. (NYSE: ORN) shares dropped 14 percent to $3.65.
PFSweb, Inc. (NASDAQ: PFSW) fell 12 percent to $5.60 after reporting downbeat Q4 earnings.
Phunware Inc. (NASDAQ: PHUN) shares declined 11.8 percent to $45.00.
PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) fell 11.2 percent to $5.53 after jumping 64.52 percent on Monday.
Emerge Energy Services LP (NYSE: EMES) dropped 10.9 percent to $2.2377.
Bio-Path Holdings, Inc. (NASDAQ: BPTH) dipped 10.1 percent to $24.99.
Gritstone Oncology, Inc. (NASDAQ: GRTS) dropped 9.7 percent to $12.05.
Covenant Transportation Group, Inc. (NASDAQ: CVTI) fell 8.8 percent to $19.51 on worse-than-expected Q1 guidance.
B Communications Ltd (NASDAQ: BCOM) shares dropped 7.8 percent to $3.66.
Del Taco Restaurants, Inc. (NASDAQ: TACO) fell 6.5 percent to $9.90 after the company reporter lower-than-expected Q4 EPS results. The company also issued FY19 EPS guidance below analyst estimates and FY19 sales on the low-end of analyst estimates.
Revlon Inc (NYSE: REV) declined 6.4 percent to $18.11 after the company reported lower-than-expected Q4 EPS and sales results.
Yext, Inc. (NYSE: YEXT) shares fell 4.3 percent to $22.03. Yext priced its 6.1 million share offering of common stock at $21.50 per share.
Cactus Inc (NYSE: WHD) dropped 4 percent to $36.25 after a shareholder of the company priced an 8.5 million share offering at $36.25 per share.